MINNEAPOLIS –– Advancing the treatment of peripheral artery disease, Medtronic, Inc. today announced approval by the U.S. Food and Drug Administration (FDA) of the Assurant® Cobalt Iliac ...

Patients who develop postthrombotic syndrome and obstructed iliac veins following deep vein thrombosis (DVT) experience more symptom relief when endovascular therapy is added to usual care, according ...

Becton, Dickinson and Company BDX, popularly known as BD, recently announced that it has received CE Mark approval in the European Union for its Revello Vascular Covered Stent. With this approval, BD ...

Self-expanding polyethylene terephthalate and polytetrafluoroethylene (PTFE)-covered stents have been shown to decrease the need for repeat procedures in the iliac artery. [33] Similar to surgical ...

Abbott (Abbott Park, Illinois) reported FDA approval for its Omnilink Elite vascular balloon-expandable stent system for the treatment of iliac artery disease, a form of peripheral artery disease (PAD ...

Post-thrombotic syndrome is common after deep-vein thrombosis and can cause severe symptoms involving the limbs that impair patients’ activity and quality of life. Endovascular therapy can eliminate ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved a new low-profile balloon-expandable stent. The stent is compatible with 6-French sheaths with ...

The efficacy and safety of endovascular therapy in patients with moderate or severe post-thrombotic syndrome and iliac-vein obstruction was evaluated in the C-TRACT trial. The intervention, a ...

Stents open up narrowed arteries. When you have a stent placed, it’s meant to be permanent. Stents can stay in your body without breaking down over time, though in some cases they may need replacement ...

The treatment of patients with peripheral arterial disease has evolved tremendously since the early 1960s, when Charles Dotter first successfully revascularized a superficial femoral artery occlusion ...